Biogen (BIIB) Could Be Worth $375-475/Share in a Takeover - RBC Capital's Yee
Go back to Biogen (BIIB) Could Be Worth $375-475/Share in a Takeover - RBC Capital's Yee| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 199.71 +3.13 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $196.58 | 52 Week High | $333.65 | |||
| Open | $199.48 | 52 Week Low | $223.02 | |||
| Day High | $200.98 | P/E | 25.57 | |||
| Day Low | $194.74 | EPS | $7.81 | |||
| Volume | 1,675,269 | |||||
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 55.90 +1.21 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.69 | 52 Week High | $108.96 | |||
| Open | $55.51 | 52 Week Low | $62.12 | |||
| Day High | $56.31 | P/E | N/A | |||
| Day Low | $54.96 | EPS | $-1.27 | |||
| Volume | 3,014,555 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 115.48 +1.61 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $113.87 | 52 Week High | $65.46 | |||
| Open | $113.97 | 52 Week Low | $47.97 | |||
| Day High | $115.63 | P/E | 78.56 | |||
| Day Low | $113.00 | EPS | $1.47 | |||
| Volume | 10,593,825 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 466.79 +15.16 (3.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $451.63 | 52 Week High | $134.71 | |||
| Open | $455.65 | 52 Week Low | $73.31 | |||
| Day High | $468.18 | P/E | N/A | |||
| Day Low | $453.21 | EPS | $-1.98 | |||
| Volume | 2,034,572 | |||||
